11.32
1.98%
+0.22
Maravai LifeSciences Holdings Inc (MRVI) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
10.88%
74.14
|
66.86 | 68.91 | 79.03 | 204.71 |
Cost Of Revenue |
4.30%
35.11
|
36.69 | 43.27 | 33.68 | 53.25 |
Gross Profit |
29.34%
39.03
|
30.18 | 25.64 | 45.35 | 151.46 |
Operating Expenses
|
1.29%
46.18
|
45.60 | 37.26 | 42.82 | 42.21 |
Interest Income/Expense |
32.34%
15.40
|
11.64 | 7.022 | 11.83 | 10.18 |
Benefits Costs and Expenses |
765.74%
-582.04
|
87.43 | 82.28 | 83.55 | 108.84 |
Costs And Expenses |
1.20%
81.29
|
82.28 | 80.53 | 76.49 | 95.47 |
Operating Income/Loss |
53.62%
-7.15
|
-15.42 | -11.61 | 2.533 | 109.25 |
Income/Loss From Continuing Operations Before Tax |
3,291%
656.19
|
-20.56 | -13.36 | -4.523 | 95.88 |
Income Tax Expense/Benefit, Deferred |
13,924%
764.75
|
-5.532 | -2.756 | -1.52 | 7.011 |
Income Tax Expense/Benefit |
14,130%
766.17
|
-5.461 | -1.421 | -3.175 | 8.447 |
Income/Loss From Continuing Operations After Tax |
628.26%
-109.98
|
-15.10 | -11.94 | -1.348 | 87.43 |
Net Income/Loss
|
628.26%
-109.98
|
-15.10 | -11.94 | -1.348 | 87.43 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
53.44%
-4.023
|
-8.64 | -5.402 | -1.281 | 49.80 |
Basic Average Shares |
99.94%
0.074
|
131.93 | 131.86 | 131.74 | 0.027 |
Diluted Average Shares |
99.94%
0.074
|
131.93 | 131.86 | 131.74 | - |
Basic Earnings Per Share |
1,500%
-0.80
|
-0.05 | -0.05 | - | 0.28 |
Diluted Earnings Per Share |
1,500%
-0.80
|
-0.05 | -0.05 | - | 0.30 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):